Prion-like transmission and propagation of human β-amyloid to the bank vole rodent model
By
Michele Angelo Di Bari
Rosalia Bruno
Geraldina Riccardi
Ilaria Vanni
Claudia D’Agostino
Romolo Nonno
Elena De Cecco
Anna Burato
Giuseppe Legname
Franco Cardone
Fabio Moda
Giorgio Giaccone
Marcella Catania
Giuseppe Di Fede
Fabrizio Tagliavini
Umberto Agrimi
June 30, 2026
Clinical Scorecard: Transmission and Spread of Human β-Amyloid in a Bank Vole Model: Insights into Prion-like Mechanisms
At a Glance
Category Detail
Condition Alzheimer’s disease (AD) Key Mechanisms Prion-like transmission of amyloid-β (Aβ) and hyperphosphorylated Tau (pTau) aggregates. Target Population Individuals with sporadic and familial Alzheimer’s disease. Care Setting Research laboratories studying neurodegenerative diseases.
Key Highlights
Aβ and pTau pathology were demonstrated in bank voles inoculated with human brain homogenates. Aβ seeds were shown to propagate in a prion-like manner in a non-human host. The study provides evidence for the transmissibility of human Aβ in a wild-type rodent model. Guideline-Based Recommendations
Diagnosis
Diagnosis of AD is based on clinical assessment and imaging studies. Management
Management strategies focus on symptomatic treatment and supportive care. Monitoring & Follow-up
Regular cognitive assessments and monitoring of behavioral changes. Risks
Potential for iatrogenic transmission of AD through contaminated human-derived materials. Patient & Prescribing Data
Patients diagnosed with sporadic and familial Alzheimer’s disease.
Current treatments do not address the underlying prion-like mechanisms of Aβ and pTau.
Clinical Best Practices
Utilize animal models to study the mechanisms of AD transmission. Consider genetic factors in familial cases of AD for targeted research. Related Resources & Content
